New England Biolabs® opens subsidiary in India
"This new subsidiary office will provide the scientific research community in
"It is exciting to see the continued growth of
NEB also maintains subsidiary offices in
For more information, visit www.neb.com or e-mail [email protected]
About New England Biolabs
For over 50 years, New England Biolabs (NEB) has pioneered the discovery and production of innovative products tailored for molecular biology research. Our commitment to scientific discovery is evident in all that we do, including our ever-expanding product portfolio, investment in our basic and applied research program, and support of customers' research in academia and industry, including cutting-edge technologies for use in molecular diagnostics and nucleic-acid vaccines development. Guided by our founding principles, NEB proactively invests in efforts to improve the well-being of our employees, surrounding communities, as well as the future of our planet. NEB remains a privately held company with global reach, supported by our headquarters in
NEW ENGLAND BIOLABS® and NEB® are registered trademarks of New England Biolabs, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-england-biolabs-opens-subsidiary-in-india-302705196.html
SOURCE New England Biolabs, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INTURAI EXPANDS CRITICAL INFRASTRUCTURE SECURITY CAPABILITIES THROUGH PROPOSED DOMECOMMAND ACQUISITION AS GLOBAL COUNTER-UAS FOCUS INTENSIFIES
- Lake Victoria Gold Announces Maiden Mineral Resource at Tembo of 480,100 Inferred and 99,700 Indicated Ounces, Adjacent to Barrick's Bulyanhulu Mine
- PhilWeb Q2 Net Income Surges 237% Q-Q on Digital Gaming Solutions Growth and AI Pilot
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share